These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 375635)

  • 1. [Biological preparations in the overall therapy of children convalescing after dysentery].
    Kurnosova NA; Zatsepin IuK; Feklisova LV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Apr; (4):21-5. PubMed ID: 375635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of colibacterin on the excretion of bacteria in children with dysentery].
    Skirda GI
    Pediatriia; 1974; 53(5):66-8. PubMed ID: 4603499
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunity indices during the vaccinal therapy of protracted forms of dysentery in children].
    Elkina SI; Beĭlina VB; Ispolatovskaia EO; Kalina NG; Novikova AV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Jul; (7):74-8. PubMed ID: 2683527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical evaluation of antibioticoresistant colibacterin during treatment of dysentery Sonnei].
    Bogdanov IL; Goliusova EV; Bass TM; Ozerianskaia NM; Golovko IA
    Vrach Delo; 1974 Jun; (6):146-7. PubMed ID: 4619244
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical manifestations and treatment of intestinal dysbacteriosis in patients with Flexner's dysentery].
    Shakhmardanov MZ; Luchshev VI; Bondarenko VM; Isaeva NN
    Klin Med (Mosk); 1997; 75(7):47-9. PubMed ID: 9411056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of colibacterin in children with dysentery and in some other intestinal infections].
    Riabinskaia TF; Kanshina OA; D'iakova EI; Koroleva AI
    Vopr Okhr Materin Det; 1967 Jun; 12(7):89-90. PubMed ID: 4887098
    [No Abstract]   [Full Text] [Related]  

  • 7. [Parenteral use of a therapeutic vaccine in acute dysentery].
    Ermakova ZF
    Sov Med; 1979 May; (5):83-6. PubMed ID: 377515
    [No Abstract]   [Full Text] [Related]  

  • 8. Shigella Sonnei vaccine.
    Drugs R D; 1999 Sep; 2(3):222-3. PubMed ID: 10641235
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experience in using streptomycin-resistant colibacterin in treating chronic Sonne dysentery in children].
    Petrichenko VG; Ozerianskaia NM
    Pediatriia; 1974; 53(5):72. PubMed ID: 4603529
    [No Abstract]   [Full Text] [Related]  

  • 10. Interbacterial transfer of R factor in the human intestine: in-vivo acquisition of R-factor-mediated kanamycin resistance by a multiresistant strain of Shigella sonnei.
    Farrar WE; Eidson M; Guerry P; Falkow S; Drusin LM; Roberts RB
    J Infect Dis; 1972 Jul; 126(1):27-33. PubMed ID: 4556721
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of a polyvalent protein-polysaccharide dysentery oral vaccine.
    Zhang HM; Li YP; Song LH; Yu XL; Liu NH; Kong XE; Li L; Zhai YL
    Chin Med J (Engl); 1987 May; 100(5):425-8. PubMed ID: 3115716
    [No Abstract]   [Full Text] [Related]  

  • 12. The changing epidemiology of bacillary dysentery and characteristics of antimicrobial resistance of Shigella isolated in China from 2004-2014.
    Chang Z; Zhang J; Ran L; Sun J; Liu F; Luo L; Zeng L; Wang L; Li Z; Yu H; Liao Q
    BMC Infect Dis; 2016 Nov; 16(1):685. PubMed ID: 27863468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamics of bacterial polysensitization in acute dysentery in children depending on the species of the causative agent].
    Karavaev VE
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Mar; (3):72-5. PubMed ID: 3296580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intestinal dysbacteriosis in patients with dysentery and gastritis with secretory insufficiency].
    Zasukha GP; Makos' RP
    Vrach Delo; 1985 Feb; (2):108-10. PubMed ID: 3887752
    [No Abstract]   [Full Text] [Related]  

  • 15. [Vaccine therapy of children with Shigella sonnei carrier state following dysentery caused by S. sonnei].
    Petrychenko VH; Bidnenko SI
    Pediatr Akus Ginekol; 1971; 4():11-3. PubMed ID: 4948553
    [No Abstract]   [Full Text] [Related]  

  • 16. [The mechanisms of action of probiotics on lymphocyte function in acute shigellosis].
    Isaeva NP; Shakhmardanov MZ; Zemskova LN; Grigor'ev AV; Luchshev VI
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):107-8. PubMed ID: 7879496
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic determinants of virulence in Shigella and dysenteric strains of Escherichia coli: their involvement in the pathogenesis of dysentery.
    Kopecko DJ; Baron LS; Buysse J
    Curr Top Microbiol Immunol; 1985; 118():71-95. PubMed ID: 2414072
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of the effectiveness of lactobacterin in the treatment of dysentery, colienteritis, and dysbacteriosis of the intestines in children].
    Krasik LL; Podchas NI; Spiridonov ME; Ivakina AM; Gol'ianova GA; Golshmidt BK; Mitrofanova IG; Chernetskaya EM; Blyuger AF; Stolygvo NS; Veksler KhM; Blauberga BT; Grote IT; Tsaune RA
    Vopr Okhr Materin Det; 1974 Sep; 19(9):33-6. PubMed ID: 4418993
    [No Abstract]   [Full Text] [Related]  

  • 19. [The excretion of Shigella antigens in persons recovering from dysentery].
    Erkinbekova BK; Karal'nik BV; Aleshin AI; Nurkina NM
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (5-6):21-4. PubMed ID: 1455962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Colicin as a factor of Escherichia and the Shigella antagonism during dysentery infection. I. Preparation of apurified colicin V preparation and study of its activity].
    Gerok GI; Litinskiĭ IuI; Godovannyĭ VA
    Zh Mikrobiol Epidemiol Immunobiol; 1971 Dec; 48(12):117-21. PubMed ID: 4943706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.